Ian R Henderson Selected Research

Porins

12/2020	Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surface.
12/2014	Natural and vaccine-mediated immunity to Salmonella Typhimurium is impaired by the helminth Nippostrongylus brasiliensis.
6/2009	The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ian R Henderson Research Topics

Disease

22	Infections 11/2021 - 11/2002
2	Thrombosis (Thrombus) 01/2019 - 12/2015
2	Inflammation (Inflammations) 01/2019 - 12/2015
2	Sepsis (Septicemia) 01/2018 - 01/2016
2	Bronchiectasis 01/2017 - 08/2014
2	Salmonella Infections (Salmonellosis) 06/2011 - 02/2011
2	Bacteremia 04/2010 - 06/2009
1	Tetraploidy 01/2022
1	Cystic Fibrosis (Mucoviscidosis) 11/2021
1	Granuloma 01/2020
1	Vesicular Stomatitis 01/2019
1	Human Influenza (Influenza) 01/2019
1	Measles 01/2019
1	Gram-Negative Bacterial Infections 01/2018
1	Diphtheria 01/2018
1	Tetanus 01/2018
1	Blister (Bulla) 01/2018
1	Chronic Renal Insufficiency 01/2018
1	Pseudomonas Infections 01/2017
1	Hookworm Infections (Hookworm Infection) 12/2014
1	Dengue (Dengue Fever) 08/2014
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2014
1	Typhoid Fever (Typhoid) 12/2012
1	Atrophy 11/2012
1	HIV Infections (HIV Infection) 04/2010
1	Bacterial Infections (Bacterial Infection) 12/2004

Drug/Important Bio-Agent (IBA)

7	VaccinesIBA 01/2018 - 06/2009
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2004
6	AntibodiesIBA 11/2021 - 04/2010
5	AntigensIBA 01/2019 - 06/2009
4	Immunoglobulin G (IgG)IBA 11/2021 - 08/2014
4	Complement System Proteins (Complement)IBA 01/2018 - 04/2014
3	PorinsIBA 12/2020 - 06/2009
2	Glycoproteins (Glycoprotein)IBA 01/2019 - 12/2015
2	Type V Secretion SystemsIBA 01/2016 - 11/2011
2	FlagellinIBA 06/2011 - 06/2009
2	Membrane Proteins (Integral Membrane Proteins)IBA 04/2010 - 06/2009
1	Immunoglobulin A (IgA)IBA 11/2021
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	FibrinIBA 01/2019
1	Lipoproteins (Lipoprotein)IBA 11/2018
1	glyceryl methyl methacrylateIBA 01/2018
1	Complement Factor B (Factor B)IBA 01/2018
1	ToxoidsIBA 01/2018
1	Bacterial AntigensIBA 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2016
1	Serine Proteases (Serine Protease)IBA 01/2016
1	C-Type Lectins (C-Type Lectin)IBA 12/2015
1	Blocking AntibodiesIBA 08/2014
1	O Antigens (O Antigen)IBA 08/2014
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 04/2014
1	Virulence Factors (Pathogenicity Factors)IBA 01/2013
1	Polysaccharides (Glycans)IBA 12/2012
1	GlucocorticoidsIBA 11/2012
1	Subunit VaccinesIBA 06/2011
1	Bacterial VaccinesIBA 06/2009
1	Enterotoxins (Enterotoxin)IBA 10/2006
1	antiarrhythmic peptide (AAP)IBA 11/2002

Therapy/Procedure

2	Plasmapheresis 11/2021 - 01/2017
1	Aftercare (After-Treatment) 01/2019
1	Ligation 12/2015